Beinat, Corinne published the artcileStructure-activity relationship studies of SEN12333 analogues: Determination of the optimal requirements for binding affinities at α7 nAChRs through incorporation of known structural motifs, Category: pyridazine, the main research area is structure cognition enhancer preparation acetylcholine receptor; Acetylcholine receptor; CNS; Structure–activity relationships; α7 nicotinic receptors.
Alpha7 nicotinic acetylcholine receptors (nAChRs) have implications in the regulation of cognitive processes such as memory and attention and have been identified as a promising therapeutic target for the treatment of the cognitive deficits associated with schizophrenia and Alzheimer’s disease (AD). Structure affinity relationship studies of the previously described α7 agonist SEN12333, have resulted in the identification of compound I, a potent and selective agonist of the α7 nAChR with enhanced affinity and improved physicochem. properties over the parent compound (SEN12333).
European Journal of Medicinal Chemistry published new progress about Cognition enhancers. 17259-32-4 belongs to class pyridazine, name is 4-(6-Chloropyridazin-3-yl)morpholine, and the molecular formula is C8H10ClN3O, Category: pyridazine.
Referemce:
Pyridazine – Wikipedia,
Pyridazine | C4H4N2 – PubChem